SOPHIA GENETICS SA's ticker is and the CUSIP is H82027105. A total of 33 filers reported holding SOPHIA GENETICS SA in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,782 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 2,014,024 | $15,568,000 | 0.58% |
| GENERATION INVESTMENT MANAGEMENT LLP | 6,789,560 | $52,483,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 829,930 | $6,415,000 | 0.21% |
| BANK PICTET & CIE (ASIA) LTD | 64,420 | $498,000 | 0.14% |
| BANQUE PICTET & CIE SA | 2,096,420 | $16,205,000 | 0.12% |
| Moloney Securities Asset Management, LLC | 71,450 | $552,000 | 0.11% |
| GENERAL ELECTRIC CO | 1,111,111 | $8,588,888 | 0.09% |
| Bank Pictet & Cie (Europe) AG | 227,600 | $1,759,000 | 0.07% |
| RTW INVESTMENTS, LP | 226,589 | $1,752,000 | 0.04% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 287,406 | $2,222,000 | 0.03% |